PROCEL
Dead / Abandoned — Abandoned — failure to respond (as of 28 Feb 2023)
What this means for you
This application is over — abandoned 17 Feb 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97484095
- Mark type
- Stylized text
- Filed
- 30 Jun 2022
- Abandoned
- 17 Feb 2023
- Attorney of record
- Karen Won
Goods and services
- Class 005 — Pharmaceuticals: Biopharmaceutical preparations; Biopharmaceutical preparations in the nature of T-cell allogenic therapies; Cell therapies for use in oncology, immunology, and immuno-oncology; Therapeutic agents for targeting tumors; Biological components, namely, genetically engineered T-cells, being a component in therapeutic preparations for use in diseases and disorders of oncology, immunology, and immuno-oncology; Human cells for medical and therapeutic use; T-cells for medical and therapeutic use
Owner
- Kiromic Biopharma, Inc., Houston, TX, US
Prosecution history
- 01 Mar 2023 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 28 Feb 2023 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 28 Feb 2023 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 16 Aug 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 16 Aug 2022 — NON-FINAL ACTION E-MAILED
- 16 Aug 2022 — NON-FINAL ACTION WRITTEN
- 16 Aug 2022 — ASSIGNED TO EXAMINER
- 20 Jul 2022 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 04 Jul 2022 — NEW APPLICATION ENTERED